Plant ID: NPO18732
Plant Latin Name: Vetiveria Zizanioides
Taxonomy Genus: Chrysopogon
Taxonomy Family: Poaceae
NCBI TaxonomyDB:
167337
Plant-of-the-World-Online:
n.a.
Ingredient ID: NPC478979
Ingredient ID: NPC478978
Ingredient ID: NPC478977
Ingredient ID: NPC256377
Ingredient ID: NPC248902
Ingredient ID: NPC206090
Ingredient ID: NPC185498
Ingredient ID: NPC183096
Ingredient ID: NPC145192
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Histone acetyltransferase | NCOA3 | Nuclear receptor coactivator 3 | Q9Y6Q9 | CHEMBL1615382 |
Therapeutic Target | Isomerase | TOP2B | DNA topoisomerase II beta | Q02880 | CHEMBL3396 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 978 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT00004010 | Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00017251 | Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00004031 | SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00180791 | High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood | medulloblastoma | Etoposide (NPC185498) | NP level |
NCT01059071 | Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT04684017 | Anlotinib Plus Etoposide and Carboplatin as First-line Treatment for Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00151242 | Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00003578 | High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02337712 | Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00691210 | Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies | Hodgkins lymphoma;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT04028050 | A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00043927 | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00024193 | Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00822120 | S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00088530 | BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00002461 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003573 | Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma | brain neoplasm | Etoposide (NPC185498) | NP level |
NCT01258634 | A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response | osteosarcoma | Etoposide (NPC185498) | NP level |
NCT01331590 | Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00554788 | Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00616785 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | lung cancer | Etoposide (NPC185498) | NP level |
NCT00274924 | Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00005964 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00077285 | Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT00878254 | Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00556127 | Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00276731 | Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT04730999 | Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01165112 | Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma or Hodgkin Lymphoma | diffuse large B-cell lymphoma;Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00003602 | Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT00630565 | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT01959698 | Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00002961 | Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT04002947 | Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00002822 | Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT04154189 | A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
NCT00047138 | Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | kidney cancer | Etoposide (NPC185498) | NP level |
NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00003937 | Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT01604863 | A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies | cancer | Etoposide (NPC185498) | NP level |
NCT00017368 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00354107 | Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma | anaplastic large cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00812266 | Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00004904 | Stem Cell Transplantation in Treating Patients With Hematologic Cancer | graft versus host disease;chronic myeloproliferative disorder;leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT02722369 | STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00018954 | Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT04139304 | A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT02421939 | A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00073918 | Iodine I 131 Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | anaplastic large cell lymphoma;MALT lymphoma;Waldenstrom macroglobulinemia;Burkitts lymphoma;diffuse large B-cell lymphoma;follicular lymphoma;lymphoblastic lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00193531 | Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
NCT01097057 | Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00003423 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT04740021 | Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00275015 | Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia | chronic lymphocytic leukemia | Etoposide (NPC185498) | NP level |
NCT00002590 | Combination Chemotherapy in Treating Children With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00209222 | Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00006669 | Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00002550 | Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00742924 | Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT00003053 | Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed | lung cancer | Etoposide (NPC185498) | NP level |
NCT03018626 | R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00504140 | Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
NCT01415765 | MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00193505 | Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00098774 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01864109 | Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma | Ewing sarcoma | Etoposide (NPC185498) | NP level |
NCT00003158 | S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT02504359 | Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma | plasma cell leukemia;multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00012051 | Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00984997 | Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors | lung cancer | Etoposide (NPC185498) | NP level |
NCT02636322 | Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00324467 | Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | neoplasm of mature B-cells;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00003243 | Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer | myelodysplastic/myeloproliferative disease;leukemia;lymphoma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT00180908 | Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children | osteosarcoma | Etoposide (NPC185498) | NP level |
NCT01492556 | Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00003299 | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00004903 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00549848 | Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00002905 | Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00217503 | Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02836639 | BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00450801 | R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00006012 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT04322318 | A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT | kidney Wilms tumor | Etoposide (NPC185498) | NP level |
NCT02875457 | Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02412267 | Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00078988 | High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade Gliomas | brain neoplasm | Etoposide (NPC185498) | NP level |
NCT03781869 | Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00810017 | Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00216125 | Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01371981 | Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | myeloid sarcoma | Etoposide (NPC185498) | NP level |
NCT02429700 | TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors | ovarian sex cord-stromal tumor | Etoposide (NPC185498) | NP level |
NCT00002557 | Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides | lymphoma | Etoposide (NPC185498) | NP level |
NCT03432598 | Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT03711305 | Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01589159 | A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes | breast cancer | Etoposide (NPC185498) | NP level |
NCT00039130 | Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT04696575 | Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02574728 | Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors | cancer | Etoposide (NPC185498) | NP level |
NCT02580994 | Pembrolizumab in Untreated Extensive SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00049036 | Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
NCT01197560 | Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00002936 | Altretamine and Etoposide in Treating Patients With HIV-Related Cancer | lymphoma;sarcoma | Etoposide (NPC185498) | NP level |
NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Etoposide (NPC185498) | NP level |
NCT04044222 | A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT00499018 | Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00002756 | Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT04234607 | A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01220297 | Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT | Abnormality of blood and blood-forming tissues | Etoposide (NPC185498) | NP level |
NCT00187083 | A Study of Children With Refractory or Relapsed ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00033696 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00723658 | S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia | lymphoma | Etoposide (NPC185498) | NP level |
NCT00880243 | Effect of Priming During Induction and Consolidations in Younger Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT04702880 | A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00416676 | Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00255723 | Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00927875 | A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02499770 | Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03182244 | A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FLT3 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00002657 | SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00002912 | Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00025103 | Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney | kidney cancer | Etoposide (NPC185498) | NP level |
NCT00003631 | Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT03623087 | SIMPLE Chemotherapy for NK Lymphoma/Leukaemia | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00006258 | Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT00801918 | Denileukine Diftitox for Relapsed ALCL | lymphoma | Etoposide (NPC185498) | NP level |
NCT00002638 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT03064867 | Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00003401 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT01450761 | Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00066222 | Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00002691 | Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01899066 | Efficacy Study of Lucentis in the Treatment of Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00028665 | Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02400281 | Study of Crenolanib Combined With Chemotherapy in FLT3-mutated Acute Myeloid Leukemia Patients | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00003859 | Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT01906814 | Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00001339 | A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | carcinoma | Etoposide (NPC185498) | NP level |
NCT00020566 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT00304070 | Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
NCT00002740 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00926640 | A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00049218 | Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT02638428 | Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT02595424 | Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery | pancreatic endocrine carcinoma | Etoposide (NPC185498) | NP level |
NCT03164057 | A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT03019640 | Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00878449 | A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer | neoplasm | Etoposide (NPC185498) | NP level |
NCT02243436 | Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT01481272 | Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00002715 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT04543890 | A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00003190 | Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia | acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia with maturation;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia | Etoposide (NPC185498) | NP level |
NCT00005863 | Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
NCT03583710 | Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
NCT00791154 | QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00780104 | Sirolimus in Combination With MEC in High Risk Myeloid Leukemias | chronic myelogenous leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00005987 | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00005834 | S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT04256421 | A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02784015 | Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
NCT04452370 | Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00027846 | Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma | brain neoplasm | Etoposide (NPC185498) | NP level |
NCT01169636 | Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT04472949 | Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00544596 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00003052 | Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT01830777 | Brentuximab Vedotin + Re-induction Chemotherapy for AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT03517137 | Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT02436707 | Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02443077 | Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
NCT02228512 | Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas | Castleman disease;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT02861573 | Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) | prostate cancer | Etoposide (NPC185498) | NP level |
NCT00084838 | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT00002598 | Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00002675 | Chemotherapy in Treating Patients With Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT02366663 | BEAM vs. 90-Yttrium Ibritumomab Tiuxetan (Zevalin®)/BEAM With ASCT for Relapsed DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT02512926 | Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children | leukemia | Etoposide (NPC185498) | NP level |
NCT04878016 | A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00499616 | Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT03991884 | Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT02949895 | Study of BMS-986012 in Subjects With Small Cell Lung Caner | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03504410 | Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00808899 | Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT04712903 | Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00576979 | Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT05354700 | A Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy in Patients With Extensive Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01181271 | Tandem Auto-Allo Transplant for Lymphoma | chronic lymphocytic leukemia;diffuse large B-cell lymphoma;Hodgkins lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00003114 | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00798148 | 131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT04833114 | Polatuzumab Vedotin Plus Rituximab, Ifosfamide, Carboplatin and Etoposide (Pola-R-ICE) Versus R-ICE Alone in Second Line Treatment of Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00324298 | Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles | testicular neoplasm | Etoposide (NPC185498) | NP level |
NCT00315705 | A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT01439568 | A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00345865 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00187161 | Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT02405676 | BNHL-2015 for Children or Adolescents in China | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
NCT04372927 | ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00043979 | Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | sarcoma | Etoposide (NPC185498) | NP level |
NCT00003262 | Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection | lymphoma | Etoposide (NPC185498) | NP level |
NCT00051311 | Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
NCT02937116 | First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
NCT00004898 | Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT01525927 | Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity | neoplasm of oropharynx | Etoposide (NPC185498) | NP level |
NCT00135135 | Therapy for Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00079040 | Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00369317 | Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes | acute basophilic leukemia;acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT00500890 | Treatment of Tumors of the Choroid Plexus Epithelium | choroid plexus neoplasm | Etoposide (NPC185498) | NP level |
NCT00002658 | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00002610 | Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | kidney cancer | Etoposide (NPC185498) | NP level |
NCT04356690 | Etoposide in Patients With COVID-19 Infection | COVID-19 | Etoposide (NPC185498) | NP level |
NCT02870907 | Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009) | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00387699 | Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00372593 | Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT02070458 | Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00882076 | Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias | leukemia | Etoposide (NPC185498) | NP level |
NCT00003084 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
NCT04699838 | Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02947113 | Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00514540 | Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
NCT00002854 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer | cancer | Etoposide (NPC185498) | NP level |
NCT05466318 | ChiCGB vs BEAM in High-risk or R/R Lymphomas | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT05008224 | Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT03161054 | Metronomic Chemotherapy in Elderly Non-fit Patients With Aggressive B-Cell Lymphomas | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT03669783 | Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm) | childhood kidney neoplasm | Etoposide (NPC185498) | NP level |
NCT00012311 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT01178645 | Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT01063439 | BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) | lymphoma | Etoposide (NPC185498) | NP level |
NCT00571493 | VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT01064466 | Pharmacogenomics IND EXEMPT SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00764907 | Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT03016871 | Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT05458180 | CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00589056 | Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | lung cancer | Etoposide (NPC185498) | NP level |
NCT02194049 | Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00006695 | Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT03385096 | Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT02733107 | The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00186849 | Therapy for Children With Advanced Stage High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT03519971 | Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01076231 | Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00811993 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT01435018 | Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS | HIV-1 infection | Etoposide (NPC185498) | NP level |
NCT00002509 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT04924101 | Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00005022 | Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00653068 | Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System | neoplasm | Etoposide (NPC185498) | NP level |
NCT00005612 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
NCT00072280 | Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT03568994 | Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT01117441 | International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT04221035 | High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00242996 | Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02949258 | Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer | gastric cancer | Etoposide (NPC185498) | NP level |
NCT03206671 | Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
NCT00002945 | High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT03041311 | Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT05294055 | Mecapegfilgrastim With Chemotherapy for Peripheral Blood Stem Cell Mobilization in MM and Lymphoma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT03066778 | A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00004186 | Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT02815592 | Trial of BMS-986012 in Combination With Platinum and Etoposide | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002835 | Combination Chemotherapy in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT03901118 | Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
NCT00176605 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
NCT02899728 | Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00335738 | Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT02738346 | SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00040872 | Multiple Therapies in Treating Patients With Advanced Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00061893 | Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors | sarcoma | Etoposide (NPC185498) | NP level |
NCT00265031 | HD12 for Advanced Stages | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003141 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors | brain neoplasm;neuroblastoma;sarcoma | Etoposide (NPC185498) | NP level |
NCT00002785 | Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT03699956 | RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01104025 | Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
NCT01237678 | A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00529503 | A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00083538 | Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT02819999 | A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT05270057 | Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies | Burkitts lymphoma | Etoposide (NPC185498) | NP level |
NCT00354744 | High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT00499343 | G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients | lymphoma | Etoposide (NPC185498) | NP level |
NCT00020943 | Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00716066 | Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | chronic inflammatory demyelinating polyneuropathy;Myasthenia gravis;neuromyelitis optica;Opsoclonus-Myoclonus Syndrome;Stiff-Person syndrome | Etoposide (NPC185498) | NP level |
NCT03755804 | Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT03586999 | Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00053768 | Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00017225 | Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00924209 | A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02905110 | Methotrexate and Etoposide Infusions Into the Fourth Ventricle in Children With Recurrent Posterior Fossa Brain Tumors | brain neoplasm | Etoposide (NPC185498) | NP level |
NCT00006487 | S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT04745689 | Study of AZD2811 + Durvalumab in ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002488 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy | lymphoma | Etoposide (NPC185498) | NP level |
NCT00667615 | Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00079482 | Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00124644 | Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00336024 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma | medulloblastoma;primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
NCT04917250 | GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
NCT02631252 | Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT04490421 | Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02518750 | Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00003436 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT02323737 | Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02632708 | Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00660036 | Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT02582697 | Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours | germ cell tumor | Etoposide (NPC185498) | NP level |
NCT00025623 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00002887 | Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00264953 | HD11 for Intermediate Stages | lymphoma | Etoposide (NPC185498) | NP level |
NCT04989283 | Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02570542 | Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT04996771 | Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03840902 | M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00791947 | A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00936936 | High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors | testicular carcinoma | Etoposide (NPC185498) | NP level |
NCT00025363 | Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
NCT05361395 | First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002565 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00002494 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT00002974 | Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT05298423 | Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006/KEYVIBE-006) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT05367856 | Efficacy and Safety of Chidamide Combined With BEAM Pretreatment Regimen in Autologous Transplantation for T-cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00041015 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00567567 | Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00003364 | Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00070174 | Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy | leukemia | Etoposide (NPC185498) | NP level |
NCT05453500 | Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00632853 | Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide | lung cancer | Etoposide (NPC185498) | NP level |
NCT00025324 | Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT01887340 | Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma | seminoma | Etoposide (NPC185498) | NP level |
NCT00041327 | Combination Chemotherapy Followed By Antiviral Therapy and Interferon Alfa in Treating Patients With HTLV-1-Related Adult T-Cell Leukemia/Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00026208 | Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00005867 | Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00006461 | Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor | medulloblastoma;primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
NCT00005977 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT00003597 | Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
NCT02592876 | Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma | Etoposide (NPC185498) | NP level |
NCT00682981 | A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00005998 | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT02523976 | Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia | lymphoid leukemia | Etoposide (NPC185498) | NP level |
NCT03700359 | A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002701 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00002982 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00186875 | Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00000660 | Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma | Kaposi's sarcoma | Etoposide (NPC185498) | NP level |
NCT01423500 | ALL-SCT BFM International- HSCT in Children and Adolescents With ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00398554 | Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00047281 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT02633514 | Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma | thymus neoplasm | Etoposide (NPC185498) | NP level |
NCT00470223 | Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT04063163 | A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00939653 | T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT01840566 | High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00003606 | Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT01920932 | Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00002926 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT01783535 | Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00083551 | UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00876031 | Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
NCT00005802 | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00002788 | High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00002876 | Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT05142865 | Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
NCT00004188 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00146120 | Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT03535961 | Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00004054 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
NCT00042835 | Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | lung adenocarcinoma;squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03839446 | Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT02867956 | Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
NCT00554463 | G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00168896 | A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00004900 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00732498 | Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003812 | Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT05245994 | An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00231582 | High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II | testicular neoplasm | Etoposide (NPC185498) | NP level |
NCT01178658 | Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat T Cell or Natural Killer (NK) Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00109928 | S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00202800 | Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Etoposide (NPC185498) | NP level |
NCT02660762 | Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL | leukemia | Etoposide (NPC185498) | NP level |
NCT01511562 | Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00726986 | Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT05006664 | Brentuximab Vedotin in Combination With CHEP in Patient With PTCL | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003625 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma | brain neoplasm | Etoposide (NPC185498) | NP level |
NCT00363415 | Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03273829 | Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children | leukemia | Etoposide (NPC185498) | NP level |
NCT03213977 | R-DA-EDOCH Versus R-CEOP90, w/o Upfront Auto-HSCT in Young Patients With Intermediate/High-risk DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00041054 | Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00002571 | SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
NCT02911142 | Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma | B-cell neoplasm | Etoposide (NPC185498) | NP level |
NCT00004086 | Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT02845882 | LBL-2016 for Children or Adolescents in China | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT01294670 | Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors | sarcoma | Etoposide (NPC185498) | NP level |
NCT03564704 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT00003309 | Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT00262210 | A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT04005716 | Study of Platinum Plus Etoposide With or Without BGB-A317 in Participants With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00003728 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT00004169 | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003389 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01555541 | Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00006374 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT03116971 | Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04871607 | Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT03792815 | Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL) | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT02782754 | Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma | germ cell tumor | Etoposide (NPC185498) | NP level |
NCT04380636 | Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01055314 | Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma | alveolar rhabdomyosarcoma;embryonal rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
NCT02329080 | New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT04012606 | Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00573690 | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT00002800 | Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome | neutropenia;leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT01027923 | IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT01979536 | Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma | anaplastic large cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00562978 | Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
NCT02176967 | Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma | ganglioneuroblastoma;neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00004006 | Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00002567 | High-Dose Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia in Remission | leukemia | Etoposide (NPC185498) | NP level |
NCT03043872 | Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01356680 | HD17 for Intermediate Stage Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT02402920 | Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00006455 | Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) | lymphoma | Etoposide (NPC185498) | NP level |
NCT00030719 | Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00027898 | Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT02605421 | Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT02262325 | Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002941 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003957 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01180322 | Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00003816 | Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer | chronic myeloproliferative disorder;leukemia;lymphoma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT00574080 | UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00388960 | Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02025881 | Study of Sequential High-dose Chemotherapy in Children With High Risk Medulloblastoma | medulloblastoma | Etoposide (NPC185498) | NP level |
NCT01046825 | Mature B-Cell Lymphoma And Leukemia Study III | lymphoma | Etoposide (NPC185498) | NP level |
NCT03100955 | A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer | colorectal cancer | Etoposide (NPC185498) | NP level |
NCT00303849 | Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors | anaplastic oligodendroglioma | Etoposide (NPC185498) | NP level |
NCT01451515 | NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT00365755 | Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00002521 | Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00186966 | Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT02179528 | Study of Small Doses of Etoposide as Maintenance Treatment in Small Cell Lung Cancer(SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02987244 | Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT03117751 | Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00020709 | Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | lung adenocarcinoma;squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01356290 | Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT | medulloblastoma | Etoposide (NPC185498) | NP level |
NCT01555710 | Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04520074 | Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) | ovarian cancer | Etoposide (NPC185498) | NP level |
NCT00439556 | Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant | lymphoma | Etoposide (NPC185498) | NP level |
NCT02748889 | Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04681417 | Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00005823 | Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
NCT00002588 | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00003113 | Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
NCT00028769 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | prostate cancer | Etoposide (NPC185498) | NP level |
NCT00244946 | Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00278252 | Etoposide in Treating Young Patients With Relapsed Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT03926624 | Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00809341 | R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT03811002 | Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) | lung cancer | Etoposide (NPC185498) | NP level |
NCT00007865 | Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT03077828 | Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT02631239 | MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00598169 | Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00349778 | High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT02940990 | SBRT in Multi-metastatic NSCLC Patients Which Are Pan-negative for Driver Mutations | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT05353257 | A Study to Evaluate the Efficacy and Safety of HLX10 in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002816 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT01710176 | Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy | soft tissue sarcoma | Etoposide (NPC185498) | NP level |
NCT02771743 | Response-based Treatment of High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00512252 | AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00005613 | Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003996 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT01548573 | Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00054665 | PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
NCT01993810 | Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00187005 | Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT02776605 | Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00695409 | Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01733589 | Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00143455 | Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02338518 | Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients | gastric cancer | Etoposide (NPC185498) | NP level |
NCT00983944 | Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00072527 | Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00977561 | A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00023998 | Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
NCT00002704 | Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00049439 | Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00002868 | Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00416832 | Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT05348213 | Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT05364424 | A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00666484 | Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT05224141 | Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008, KEYVIBE-008) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00504751 | Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00039195 | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00094497 | Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) | carcinoma | Etoposide (NPC185498) | NP level |
NCT03860844 | Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT04551131 | Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
NCT00351195 | Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Etoposide (NPC185498) | NP level |
NCT04660097 | Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002987 | Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00186888 | Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT02298283 | Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00025402 | Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT04774380 | Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00032019 | Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00006045 | Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT05192889 | Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00618501 | Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT02142049 | Ibrutinib and Lenalidomide With Dose Adjusted EPOCH-R in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00041210 | Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00417248 | Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00003632 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00006122 | Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00807755 | Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors | lung cancer | Etoposide (NPC185498) | NP level |
NCT00410423 | Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias | leukemia | Etoposide (NPC185498) | NP level |
NCT00551005 | Etoposide and Celecoxib in Patients With Advanced Cancer | neoplasm | Etoposide (NPC185498) | NP level |
NCT00693719 | Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT01423747 | Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00472056 | Rituximab in Addition to Autologous Transplantation With BEAM for Patients With Lymphoid Malignancies | lymphoma | Etoposide (NPC185498) | NP level |
NCT05124951 | The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell Tumors | central nervous system cancer | Etoposide (NPC185498) | NP level |
NCT02661503 | HD21 for Advanced Stages | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT01154439 | Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00367497 | Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT01947062 | Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma | squamous cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01573338 | Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00400946 | Treatment of Acute Lymphoblastic Leukemia in Children | leukemia | Etoposide (NPC185498) | NP level |
NCT00568464 | Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) | Ewing sarcoma | Etoposide (NPC185498) | NP level |
NCT00006040 | Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Etoposide (NPC185498) | NP level |
NCT00022737 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia | childhood acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT01722292 | A Study of LY2940680 in Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03467360 | Inhibition of CArbonic Anhydrase in Combination With Platinum and Etoposide-based Radiochemotherapy in Patients With Localized Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002827 | Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00887159 | A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02848183 | Optimal Treatment Strategy Based on for Pediatric AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00881166 | Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid Tumors | cancer | Etoposide (NPC185498) | NP level |
NCT00481832 | Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT01579929 | Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) | lung cancer | Etoposide (NPC185498) | NP level |
NCT00641381 | Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00002634 | Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT03061656 | Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00973882 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | prostate cancer | Etoposide (NPC185498) | NP level |
NCT00908180 | Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00004907 | Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00392834 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00070200 | Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00025064 | Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02703272 | A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT02626338 | Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00002925 | Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT03736616 | Acalabrutinib Plus RICE for Relapsed/Refractory DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT03188198 | Risk Adapted Therapy in Diffuse Large B Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02356159 | Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation | Hodgkins lymphoma;leukemia;multiple myeloma;myelodysplastic syndrome;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00717938 | A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002516 | Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT00288626 | High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study | relapsing-remitting multiple sclerosis | Etoposide (NPC185498) | NP level |
NCT00002766 | Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT00002510 | Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT04585893 | Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi | Castleman disease | Etoposide (NPC185498) | NP level |
NCT02934503 | Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03418038 | Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or Clonal Cytopenia of Undetermined Significance | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT03407144 | Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT02502708 | Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors | gliosarcoma;ependymoma;medulloblastoma | Etoposide (NPC185498) | NP level |
NCT00613223 | Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas | gliosarcoma | Etoposide (NPC185498) | NP level |
NCT00002757 | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT00453154 | Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00072384 | Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT01569204 | Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT02043587 | Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT03617432 | Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients | neoplasm | Etoposide (NPC185498) | NP level |
NCT00632827 | Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT03937843 | Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma | seminoma;testicular carcinoma | Etoposide (NPC185498) | NP level |
NCT03072771 | Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00025597 | Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma. | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00003727 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00864318 | Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis | germ cell tumor | Etoposide (NPC185498) | NP level |
NCT03168594 | Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
NCT03786783 | Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | ganglioneuroblastoma;neuroblastoma | Etoposide (NPC185498) | NP level |
NCT01013779 | Merkel Positron Emission Tomography (PET) Protocol | Merkel cell skin cancer | Etoposide (NPC185498) | NP level |
NCT01134861 | Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT03004287 | 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT03383406 | A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00458848 | Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT04951115 | A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002522 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01032070 | Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma | childhood ependymoma | Etoposide (NPC185498) | NP level |
NCT04326439 | AflacLL1901 (CHOA-AML) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT05092412 | Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02553460 | Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00003575 | Interleukin-12 Following Chemotherapy in Treating Patients With Refractory HIV-Associated Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00526396 | STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01476839 | Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00118209 | Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT05116007 | Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002517 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT03382561 | Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04000295 | Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
NCT00114738 | EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00004224 | Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT04254471 | This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00004128 | Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00008190 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00100477 | Use of Topotecan in Patients With Refractory Acute Leukemia | leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT04728230 | Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02408042 | Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) | Hodgkins lymphoma;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00401609 | G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00006734 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor | sarcoma | Etoposide (NPC185498) | NP level |
NCT00006047 | Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide | neoplasm | Etoposide (NPC185498) | NP level |
NCT00702962 | Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02371161 | Phase II of High-dose Therapy in Elderly Patients With Relapsed Aggressive NHL or Resistant to First Line Therapy | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00578864 | Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00826644 | Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00011921 | Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT03367143 | Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT01457040 | Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT04177004 | Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00003860 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT02289690 | Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04501718 | Apatinib Combined With Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children | medulloblastoma | Etoposide (NPC185498) | NP level |
NCT00126191 | Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | Burkitts lymphoma | Etoposide (NPC185498) | NP level |
NCT03298074 | Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
NCT00515138 | A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant | lymphoma | Etoposide (NPC185498) | NP level |
NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00002674 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00002688 | Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT03135977 | Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00003935 | Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma | brain neoplasm | Etoposide (NPC185498) | NP level |
NCT01092182 | Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma | Burkitts lymphoma;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00083915 | DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT01096368 | Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma | anaplastic ependymoma | Etoposide (NPC185498) | NP level |
NCT00334867 | Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT02912702 | L-DEP as an Initial Treatment for EBV-HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
NCT00568607 | Study on the Combination Regimen of Dexamethasone Ifosfamide Cisplatin Etoposide in Patients With NK/T Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00085098 | Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor | brain neoplasm | Etoposide (NPC185498) | NP level |
NCT00829205 | Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | lymphoma | Etoposide (NPC185498) | NP level |
NCT00776698 | A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer. | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01746173 | CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma | T-cell non-Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT00320359 | Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01775475 | Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
NCT00005946 | Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation | leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT00712582 | Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00005985 | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02653196 | A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors | neuroepithelial neoplasm | Etoposide (NPC185498) | NP level |
NCT00031590 | Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma | medulloblastoma | Etoposide (NPC185498) | NP level |
NCT00250718 | Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00968760 | CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies | neoplasm of mature B-cells | Etoposide (NPC185498) | NP level |
NCT00379340 | Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | Wilms tumor | Etoposide (NPC185498) | NP level |
NCT00916669 | A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Etoposide (NPC185498) | NP level |
NCT01411267 | AC220 for Children With Relapsed/Refractory ALL or AML | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00042978 | Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00967369 | Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment. | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT00003093 | Combination Chemotherapy in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT02341989 | Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer | seminoma;testicular neoplasm | Etoposide (NPC185498) | NP level |
NCT00003583 | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT05161533 | Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01756989 | ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors | glioma | Etoposide (NPC185498) | NP level |
NCT00195871 | Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma | lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT00660504 | Phase3 Study of Amrubicin With Cisplatin Versus Etoposide-cisplatin for Extensive Disease Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00003967 | Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer | fallopian tube cancer;peritoneum cancer;ovarian cancer | Etoposide (NPC185498) | NP level |
NCT00025428 | Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT05403723 | Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00193596 | Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site | neoplasm | Etoposide (NPC185498) | NP level |
NCT04981899 | A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00253435 | N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00079105 | A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years | lymphoma | Etoposide (NPC185498) | NP level |
NCT00002566 | Combination Chemotherapy With Bone Marrow Transplantation in Treating Men With Germ Cell Tumors | testicular neoplasm | Etoposide (NPC185498) | NP level |
NCT01871766 | Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
NCT00001563 | EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated Lymphoma | Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
NCT00430118 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT02372409 | Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors | anaplastic astrocytoma;glioblastoma multiforme;oligoastrocytoma;oligodendroglioma;optic nerve glioblastoma;pilocytic astrocytoma | Etoposide (NPC185498) | NP level |
NCT00749723 | Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children | medulloblastoma | Etoposide (NPC185498) | NP level |
NCT00005589 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00621361 | Phase I Safety and Tolerability Study of Cediranib (RECENTIN™, AZD2171) in Combination With Chemo in First Line Lung Cancer Patients | lung cancer | Etoposide (NPC185498) | NP level |
NCT04622228 | Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01390584 | Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00014313 | Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor | sarcoma | Etoposide (NPC185498) | NP level |
NCT00948090 | PK-directed Dose Adjustment of IV Busulfan Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
NCT04665856 | Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00536978 | Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT05026593 | A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03613597 | Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02227199 | Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT02349178 | Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00703820 | Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT01030900 | Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas | diffuse large B-cell lymphoma;Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00003650 | Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00009815 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT03553238 | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00776802 | GCS-100LE in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT01563601 | Efficacy and Safety of Obatoclax Mesylate in Combination With Carboplatin and Etoposide Compared With Carboplatin and Etoposide Alone in Chemotherapy-Naive Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01857934 | Therapy for Children With Advanced Stage Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT02639650 | Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor | gestational trophoblastic neoplasm | Etoposide (NPC185498) | NP level |
NCT02157792 | M6620 First in Human Study | neoplasm | Etoposide (NPC185498) | NP level |
NCT00070187 | Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00005780 | Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00006708 | S0019 Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02219737 | Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT01729845 | Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT04422210 | A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04675697 | Anlotinib Plus Platinum-etoposide in First-line of Extensive-stage Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01329900 | Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
NCT00005631 | Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT04778410 | Study of Magrolimab Combinations in Participants With Myeloid Malignancies | cancer | Etoposide (NPC185498) | NP level |
NCT00060385 | Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00025272 | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT02631109 | L-DEP Regimen as a Salvage Therapy for Refractory Epstein Barr Virus-induced Hemophagocytic Lymphohistiocytosis | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
NCT00427791 | Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00265889 | Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT04469530 | Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT05338541 | Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood. | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00083161 | Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00352027 | Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00002836 | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00483561 | Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy | prostate cancer | Etoposide (NPC185498) | NP level |
NCT04683198 | Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00134030 | Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma | osteosarcoma | Etoposide (NPC185498) | NP level |
NCT04346914 | Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00005090 | S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT02881086 | Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT00476190 | ALL Adult Consortium Trial: Adult ALL Trial | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00002471 | Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT00069238 | Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas | lymphoma | Etoposide (NPC185498) | NP level |
NCT03742115 | Etoposide in the First-line Treatment of Adult EBV-HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
NCT05384015 | Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00003783 | Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00080886 | Rituximab and Carmustine, Cytarabine, Etoposide, and Melphalan Followed By Autologous Hematopoietic Stem Cell Transplantation in Treating Patients With B-Cell Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT05309629 | Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00057811 | Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma | anaplastic large cell lymphoma;Burkitts lymphoma;childhood acute lymphoblastic leukemia;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00002596 | Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors | childhood germ cell tumor;testicular neoplasm | Etoposide (NPC185498) | NP level |
NCT03389087 | Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00539500 | Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00003941 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | mediastinal cancer;testicular neoplasm | Etoposide (NPC185498) | NP level |
NCT04189094 | Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00057837 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002865 | High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00007852 | Rituximab and Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00537511 | A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02039726 | (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT02538926 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | T-lymphoblastic lymphoma;T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT02763579 | A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03567642 | A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers | lung cancer | Etoposide (NPC185498) | NP level |
NCT05484583 | Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in Extensive Stage Small Cell Lung Cancer With Oligometastases | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00049595 | Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00162695 | Rhabdomyosarcoma and Malignant Soft Tissue Tumours of Childhood | rhabdomyosarcoma | Etoposide (NPC185498) | NP level |
NCT01458366 | Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide for Refractory or Relapsed Aggressive B-Cell Lymphomas | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00025636 | Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01000285 | EPOCH Chemotherapy and Bortezomib for Associated T-Cell Leukemia Lymphoma | T-cell acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00098839 | Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) | childhood acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00145002 | A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL) | adult T-cell leukemia/lymphoma | Etoposide (NPC185498) | NP level |
NCT00062439 | S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors | lung cancer | Etoposide (NPC185498) | NP level |
NCT00002514 | Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission | leukemia | Etoposide (NPC185498) | NP level |
NCT01300793 | Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide | neoplasm of mature B-cells;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00040690 | Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT00689169 | Targeted Intensification With ZBEAM and Autologous Stem Cell Transplantation in Patients With High-grade B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00004906 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT03663166 | Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00003119 | Surgery in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT03723941 | Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma | adrenal cortex carcinoma | Etoposide (NPC185498) | NP level |
NCT01025778 | Haploidentical Stem Cell Transplantation for Children With Therapy Resistant Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00426101 | Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004 | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
NCT05221645 | Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT03944772 | Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03923179 | Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00137111 | Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00482053 | Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00682383 | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00131027 | High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00003215 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00379457 | Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | sarcoma | Etoposide (NPC185498) | NP level |
NCT05389423 | Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas | Burkitts lymphoma;diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT02964013 | Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001) | neoplasm | Etoposide (NPC185498) | NP level |
NCT01653418 | Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00678327 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT04077905 | Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis. | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT01987232 | Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00304018 | Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer | leukemia;multiple myeloma;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT03229616 | BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00276809 | Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia | chronic lymphocytic leukemia | Etoposide (NPC185498) | NP level |
NCT02101853 | Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00003402 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | leukemia;lymphoma | Etoposide (NPC185498) | NP level |
NCT03458260 | Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00392886 | Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT01565772 | Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01857453 | Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas | medulloblastoma | Etoposide (NPC185498) | NP level |
NCT03794167 | BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00906945 | Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT03980925 | Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin. | digestive system neuroendocrine neoplasm | Etoposide (NPC185498) | NP level |
NCT00274950 | Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors | childhood germ cell tumor;ovarian cancer | Etoposide (NPC185498) | NP level |
NCT05076786 | Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
NCT03992911 | Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma | neuroendocrine carcinoma | Etoposide (NPC185498) | NP level |
NCT00151060 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | prostate cancer | Etoposide (NPC185498) | NP level |
NCT00577993 | Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients | lymphoma | Etoposide (NPC185498) | NP level |
NCT00083681 | DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT01677949 | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia | acute lymphoblastic leukemia;acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00006184 | Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT04560972 | LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00136084 | Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00006260 | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00871013 | Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00734877 | UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00006363 | Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia | acute basophilic leukemia;acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT04624204 | Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02306291 | Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT04203511 | INCMGA00012 in Combination With Chemoradiation in Participants With Stage III Non-Small Cell Lung Cancer (POD1UM-301) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04923776 | Liver Directed RT + Chemo-immunotherapy for ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00204646 | Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) | sarcoma | Etoposide (NPC185498) | NP level |
NCT00002531 | Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT05142696 | A Safety Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) Patients in Combination With Carboplatin, Etoposide and Tislelizumab | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04092283 | Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00274807 | Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT01914718 | Dose-adjusted EPOCH-R in MYC Positive DLBCL | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00591630 | Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00310128 | Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma | anaplastic large cell lymphoma;Lymphoma, AIDS-Related | Etoposide (NPC185498) | NP level |
NCT00025259 | Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT02686346 | Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00936156 | Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years | primitive neuroectodermal tumor | Etoposide (NPC185498) | NP level |
NCT01822496 | Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00613626 | Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT03643276 | Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017 | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT03531281 | Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant | hematopoietic and lymphoid cell neoplasm | Etoposide (NPC185498) | NP level |
NCT00003421 | Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00110110 | Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT03328104 | Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma | lymphoid leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT05384821 | Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) | Wilms tumor | Etoposide (NPC185498) | NP level |
NCT01055301 | S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT03628131 | Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT00002802 | Therapy Based on Stage of Disease and Risk Assessment in Treating Children With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00521014 | GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01251107 | Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00117598 | Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) | lymphoma | Etoposide (NPC185498) | NP level |
NCT00002714 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00005793 | A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide | leukemia | Etoposide (NPC185498) | NP level |
NCT00002697 | Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00534469 | Auto BMT for Non-M3 AML in 1st Remission in Pts =60y of Age Using Busulfan/FTBI & VP16 as a Prep R | leukemia | Etoposide (NPC185498) | NP level |
NCT01226849 | Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT03349346 | Idelalisib With Rituximab, Ifosfamide, Carboplatin, Etoposide (RICE) in Children and Adolescents | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00052923 | Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00577629 | Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT03850067 | A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00209833 | Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T | refractory anemia | Etoposide (NPC185498) | NP level |
NCT00053352 | Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors | Ovarian Embryonal Carcinoma;Ovarian Yolk Sac Tumor;teratoma;Testicular Choriocarcinoma;Testicular Yolk Sac Tumor | Etoposide (NPC185498) | NP level |
NCT00151255 | All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00912392 | Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00061919 | Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT01818908 | Trial of DA-EPOCH Regimen for NHL With HLH | hemophagocytic syndrome | Etoposide (NPC185498) | NP level |
NCT05001412 | Chemotherapy Combined With Camrelizumab and Apatinib in First-line Treatment of ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01411098 | Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002642 | SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT01681537 | Lenalidomide Plus Chemotherapy for AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00003696 | Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00002719 | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT03769935 | Maintenance Therapy for Small-cell Lung Cancer | colorectal cancer | Etoposide (NPC185498) | NP level |
NCT00086944 | Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma | diffuse large B-cell lymphoma;follicular lymphoma;Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00003284 | High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00920153 | Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01468740 | Prospective Study on HIV-related Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00350181 | Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT | acute graft vs. host disease;leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00970385 | Study About Treatment of Newly Diagnosed Non Cutaneous Peripheral T Cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT02116959 | Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00144989 | A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC | lung cancer | Etoposide (NPC185498) | NP level |
NCT00388349 | Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00021112 | Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT03118466 | Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00774046 | High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML | acute myeloid leukemia;myelodysplastic syndrome | Etoposide (NPC185498) | NP level |
NCT00559104 | Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT05058651 | Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung | small cell carcinoma | Etoposide (NPC185498) | NP level |
NCT02137928 | Carboplatin Periocular Injection for Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00869232 | UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00004110 | Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT04638790 | First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1) | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00613457 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00006032 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00002805 | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia | Etoposide (NPC185498) | NP level |
NCT00612430 | Ph II Bevacizumab + Etoposide for Pts w Recurrent MG | gliosarcoma | Etoposide (NPC185498) | NP level |
NCT01014767 | Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors | brain cancer;choroid plexus neoplasm | Etoposide (NPC185498) | NP level |
NCT03023046 | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT00002611 | Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer | kidney cancer | Etoposide (NPC185498) | NP level |
NCT00003815 | Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT01237808 | Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00179920 | Chemotherapy Treatment for Children With Intraocular Germ-Line Retinoblastoma | retinoblastoma | Etoposide (NPC185498) | NP level |
NCT00002798 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;chronic myelomonocytic leukemia;refractory anemia;refractory anemia with excess blasts | Etoposide (NPC185498) | NP level |
NCT03059667 | Immunotherapy as Second-line in Patient With Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00233987 | S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003380 | Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer | fallopian tube cancer;peritoneum cancer;ovarian cancer | Etoposide (NPC185498) | NP level |
NCT04363255 | First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01516567 | Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab Evaluation | lymphoma | Etoposide (NPC185498) | NP level |
NCT02018861 | A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) | cancer | Etoposide (NPC185498) | NP level |
NCT00985855 | Feasibility of Cetuximab Associated With Concomitant Radio-Chemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00066742 | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002649 | Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma | Burkitts lymphoma;diffuse large B-cell lymphoma;follicular lymphoma | Etoposide (NPC185498) | NP level |
NCT00572169 | UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00003194 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT00045162 | S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00002481 | Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT02265770 | An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma | childhood ependymoma | Etoposide (NPC185498) | NP level |
NCT00003621 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT04061772 | A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT02896582 | Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance | Mantle cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00658580 | Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT04696939 | Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Small Cell Lung Cancer Patients | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00002768 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission | leukemia | Etoposide (NPC185498) | NP level |
NCT03793478 | Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT01958372 | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | lung adenocarcinoma | Etoposide (NPC185498) | NP level |
NCT00058292 | Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00958022 | Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02825147 | Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma | extranodal nasal NK/T cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00137995 | R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00004176 | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00002532 | Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT04542369 | Pilot Study of PD-1inhibitor (Tislelizumab) Plus Chemotherapy as Neoadjuvant Therapy for Limited-Stage Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00109031 | Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE) | leukemia;lymphoma;cancer | Etoposide (NPC185498) | NP level |
NCT02166463 | Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma | classic Hodgkin lymphoma | Etoposide (NPC185498) | NP level |
NCT04101357 | Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411 | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00104676 | Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors | teratoma;testicular neoplasm | Etoposide (NPC185498) | NP level |
NCT00032149 | Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00869752 | MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00240097 | Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC) | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT01859741 | A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02794571 | Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT02883049 | Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT02773732 | Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT01873326 | Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | germ cell tumor | Etoposide (NPC185498) | NP level |
NCT02199184 | Dose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic Leukemia | AIDS;acute lymphoblastic leukemia;Burkitts lymphoma | Etoposide (NPC185498) | NP level |
NCT05091567 | A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02768558 | Cisplatin and Etoposide Plus Radiation Followed By Nivolumab/Placebo For Locally Advanced NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02987998 | Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT02063022 | Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma | Ewing sarcoma | Etoposide (NPC185498) | NP level |
NCT03591510 | A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML | acute myeloid leukemia | Etoposide (NPC185498) | NP level |
NCT00793845 | Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT02359162 | Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage | lymphoma | Etoposide (NPC185498) | NP level |
NCT00627354 | Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | prostate cancer | Etoposide (NPC185498) | NP level |
NCT00569985 | Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00720447 | Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00020722 | Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer | breast cancer | Etoposide (NPC185498) | NP level |
NCT00025649 | Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT01222572 | Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer | non-small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT00025610 | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT02385110 | Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis | leukemia | Etoposide (NPC185498) | NP level |
NCT00720109 | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT00278278 | Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas | Central Nervous System Neoplasm | Etoposide (NPC185498) | NP level |
NCT01949129 | Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT03321890 | Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) | unspecified peripheral T-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00003397 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00005578 | Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease | lymphoma | Etoposide (NPC185498) | NP level |
NCT00004905 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT03293173 | Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT02471911 | KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma | diffuse large B-cell lymphoma | Etoposide (NPC185498) | NP level |
NCT00933673 | New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | acute lymphoblastic leukemia | Etoposide (NPC185498) | NP level |
NCT02562365 | Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
NCT00439361 | Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT00387868 | Preoperative Treatment of Patients With High Risk Thymoma | Thymoma | Etoposide (NPC185498) | NP level |
NCT00003541 | Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00005978 | N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | neuroblastoma | Etoposide (NPC185498) | NP level |
NCT00016887 | Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00225173 | Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease | Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
NCT05468489 | To Evaluate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC | small cell lung carcinoma | Etoposide (NPC185498) | NP level |
NCT05422183 | Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer | ovarian cancer | Etoposide (NPC185498) | NP level |
NCT03570983 | A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT00052299 | Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT00058461 | Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia | Burkitts lymphoma;diffuse large B-cell lymphoma;lymphoblastic lymphoma | Etoposide (NPC185498) | NP level |
NCT04047862 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | neoplasm | Etoposide (NPC185498) | NP level |
NCT00002549 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia | leukemia | Etoposide (NPC185498) | NP level |
NCT04765098 | Tamoxifen Versus Etoposide After First Recurrence in GBM Patients | glioblastoma multiforme | Etoposide (NPC185498) | NP level |
NCT00045617 | S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer | lung cancer | Etoposide (NPC185498) | NP level |
NCT00002829 | Bone Marrow Transplantation in Treating Patients With Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00006373 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | lymphoma | Etoposide (NPC185498) | NP level |
NCT00003399 | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma | multiple myeloma | Etoposide (NPC185498) | NP level |
NCT01900509 | Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies | Hodgkins lymphoma;leukemia;non-Hodgkins lymphoma | Etoposide (NPC185498) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT00004905,NCT02385110,NCT00124644,NCT00882076,NCT00002945,NCT00618501,NCT00005863,NCT03273829,NCT00002588,NCT00002719,NCT00004086,NCT00109031,NCT01117441,NCT00005977,NCT00002704,NCT00410423,NCT00002517,NCT00004904,NCT00003402,NCT00002925,NCT00005823,NCT00002494,NCT00002471,NCT00002868,NCT00002865,NCT00536978,NCT00534469,NCT00003816,NCT00003727,NCT00040690,NCT00002658,NCT00427791,NCT00002766,NCT00006040,NCT00350181,NCT02660762,NCT00400946,NCT00613457,NCT00100477,NCT00025402,NCT00002598,NCT00002638,NCT00002531,NCT02356159,NCT00458848,NCT01900509,NCT00002816,NCT00576979,NCT00304018,NCT00002788,NCT00005802,NCT00039130,NCT00002800,NCT00005793,NCT00008190,NCT00002757,NCT00630565,NCT00003243,NCT00003602,NCT00002926,NCT00005946,NCT00002961,NCT00002805,NCT00002688,NCT00002674,NCT00002549,NCT02512926,NCT00002701,NCT00002567,NCT00070174,NCT00052299,NCT00002756,NCT00006122,NCT00018954,NCT00004898,NCT00764907,NCT00430118,NCT00002785,NCT00274807,NCT00002912,NCT00002532,NCT00003728,NCT01154439,NCT00372593,NCT00003436,NCT00003783,NCT00002514,NCT00004128,NCT00002768,NCT00006045
|
Burkitt lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KA9 |
NCT05389423,NCT00126191,NCT02199184,NCT00002649,NCT05270057,NCT00057811,NCT00058461,NCT01092182,NCT00073918
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT00109031,NCT00003597,NCT02018861,NCT00002854,NCT04778410,NCT02937116,NCT01604863,NCT02574728,NCT00881166
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
TOP2B
NCT00054665,NCT02405676,NCT01300793,NCT03206671,NCT00324467,NCT02443077,NCT00968760 |
Primary neoplasms of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
NCT00003935,NCT00003625,NCT00078988,NCT00085098,NCT00027846,NCT02905110,NCT00003141,NCT00003573
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT05076786,NCT00094497,NCT03992911,NCT00001339,NCT05142865,NCT00193531,NCT00003558,NCT03168594
|
Primary haemophagocytic lymphohistiocytosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01.23 |
NCT04551131,NCT02631109,NCT03742115,NCT04077905,NCT02912702,NCT01818908,NCT00426101,NCT01104025
|
Classical Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30.1 |
NCT02661503,NCT00025259,NCT05008224,NCT00967369,NCT02243436,NCT04044222,NCT02166463,NCT03077828
|
Peripheral T-cell lymphoma, not otherwise specifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.C |
NCT00632827,NCT03321890,NCT03586999,NCT05458180,NCT04061772,NCT00791947,NCT00970385
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
TOP2B
NCT02592876,NCT03019640,NCT00073918,NCT00002649,NCT00086944 |
GerminomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1E13 |
NCT02782754,NCT00274950,NCT01873326,NCT00002596,NCT00864318,NCT02582697
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00049036,NCT00001563,NCT00002524,NCT00002571,NCT00310128,NCT01775475
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
NCT00180908,NCT04154189,NCT00134030,NCT00023998,NCT01258634,NCT00504140
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
TOP2B
NCT00482053,NCT02219737,NCT02366663,NCT02142049,NCT01030900,NCT00073918,NCT00058461,NCT02592876,NCT03229616,NCT01092182,NCT05364424,NCT01197560,NCT04139304,NCT01181271,NCT05348213,NCT05466318,NCT00556127,NCT02471911,NCT00529503,NCT03367143,NCT02570542,NCT03019640,NCT03383406,NCT00137995,NCT03213977,NCT04002947,NCT05389423,NCT00776802,NCT00086944,NCT03018626,NCT01481272,NCT03736616,NCT01165112,NCT01555541,NCT01226849,NCT03349346,NCT02329080,NCT00591630,NCT02412267,NCT03072771,NCT02228512,NCT05221645,NCT02636322,NCT04833114,NCT01959698,NCT00689169,NCT01415765,NCT00057811,NCT03064867,NCT01914718,NCT03293173,NCT00499018,NCT00002649 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
TOP2B
NCT02349178,NCT01180322,NCT02848183,NCT03793478,NCT00003190,NCT00186966,NCT02631252,NCT01411267,NCT01677949,NCT03926624,NCT02638428,NCT02773732,NCT03182244,NCT00703820,NCT00880243,NCT02421939,NCT03164057,NCT01027923,NCT00079482,NCT03860844,NCT00002798,NCT00136084,NCT04326439,NCT02039726,NCT00780104,NCT00660036,NCT02626338,NCT00939653,NCT01830777,NCT03591510,NCT04293562,NCT00146120,NCT01729845,NCT02070458,NCT00003190,NCT01025778,NCT02306291,NCT00369317,NCT00315705,NCT00006363,NCT00512252,NCT00151255,NCT01681537,NCT00906945,NCT03839446,NCT03504410,NCT01237808,NCT02400281,NCT02632708,NCT03118466,NCT00151242,NCT03568994,NCT00774046 |
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
TOP2B
NCT00003696,NCT00589056,NCT00062439,NCT00003364,NCT00660504,NCT00006374,NCT00025272,NCT00083161,NCT00004186,NCT00002822,NCT00006487,NCT00003053,NCT03432598,NCT00045162,NCT00003284,NCT00061919,NCT00003606,NCT00003299,NCT00616785,NCT00033696,NCT01134861,NCT00726986,NCT00021112,NCT00041054,NCT00632853,NCT00621361,NCT00003860,NCT00807755,NCT00002642,NCT00984997,NCT00869752,NCT00554463,NCT00144989,NCT00003812,NCT00041015,NCT00002887,NCT00002858,NCT00387699,NCT00072527,NCT00003583,NCT00002823,NCT00004176,NCT00006012,NCT00049218,NCT00045617,NCT00003158,NCT00066222,NCT03811002,NCT03567642,NCT00011921,NCT00005022,NCT01579929,NCT00002550 |
Anaplastic large cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1LC0 |
NCT00073918,NCT01979536,NCT00354107,NCT00057811,NCT00310128
|
Neuroblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH85Z0 |
NCT00025649,NCT00798148,NCT00499616,NCT00070200,NCT02605421,NCT00578864,NCT00005978,NCT00253435,NCT00539500,NCT02771743,NCT00003119,NCT00017368,NCT00025623,NCT00017225,NCT00416676,NCT02176967,NCT01857934,NCT00135135,NCT00793845,NCT04221035,NCT00276731,NCT00004110,NCT01704716,NCT00025428,NCT00004188,NCT00024193,NCT00025597,NCT00040872,NCT00186849,NCT01059071,NCT03061656,NCT03786783,NCT00567567,NCT00002634,NCT05338541,NCT00002740,NCT00365755,NCT00003093,NCT00002802,NCT00030719,NCT00808899,NCT00025610,NCT00003141
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT01949129,NCT05453500,NCT01423747,NCT00057811,NCT02199184,NCT02101853,NCT00187005,NCT02776605,NCT00315705,NCT01677949,NCT01411267,NCT01423500,NCT02553460,NCT01025778,NCT05192889,NCT03643276,NCT02518750,NCT00549848,NCT00720109,NCT02881086,NCT00187161,NCT03020030,NCT00137111,NCT00186875,NCT03991884,NCT00476190,NCT00022737,NCT02003222,NCT03553238,NCT02043587,NCT01457040,NCT03117751,NCT00131027,NCT00098839,NCT03023046,NCT01331590,NCT00187083,NCT03860844,NCT02883049,NCT02349178
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
TOP2B
NCT03531281,NCT00051311,NCT04177004 |
Acute myelomonocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH78Y4 |
NCT00003190,NCT00002798,NCT00369317,NCT00006363
|
Acute megakaryoblastic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.36 |
NCT00003190,NCT00002798,NCT00369317,NCT00006363
|
Acute erythroid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.35 |
NCT00006363,NCT00369317,NCT00003190,NCT00002798
|
Acute monocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9NE2 |
NCT00002798,NCT00369317,NCT00003190,NCT00006363
|
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT00002611,NCT00047138,NCT00002610,NCT00025103
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT01840566,NCT02371161,NCT00367497,NCT02987244,NCT02408042,NCT00088530,NCT00712582,NCT01900509,NCT00250718,NCT00504751,NCT01097057,NCT01178645,NCT03792815,NCT01178658,NCT00350181,NCT01300793,NCT02836639,NCT03161054,NCT02356159,NCT00262210,NCT02703272,NCT00193505,NCT00324467,NCT01746173,NCT00100477,NCT00691210,NCT00481832,NCT01458366,NCT00809341,NCT03458260,NCT03794167,NCT03623087
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT01222572,NCT00776698,NCT01733589,NCT03944772,NCT02987998,NCT00240097,NCT02733107,NCT03663166,NCT04372927,NCT03840902,NCT01822496,NCT00216125,NCT04989283,NCT04092283,NCT01076231,NCT00686959,NCT00924209,NCT02947113,NCT00985855,NCT03519971,NCT02262325,NCT00191139,NCT00682383,NCT04203511,NCT00417248,NCT01565772,NCT05298423,NCT02768558,NCT01993810,NCT02940990,NCT04380636,NCT01411098
|
Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30 |
NCT02298283,NCT03517137,NCT01165112,NCT04981899,NCT00026208,NCT02227199,NCT01356680,NCT03016871,NCT03418038,NCT01181271,NCT03407144,NCT02686346,NCT00388349,NCT04871607,NCT01920932,NCT00691210,NCT02408042,NCT00667615,NCT01569204,NCT01030900,NCT03755804,NCT02356159,NCT04638790,NCT00352027,NCT01476839,NCT01251107,NCT00439361,NCT01169636,NCT01468740,NCT01900509,NCT00225173
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT02356159,NCT00003399,NCT00004904,NCT00083915,NCT00572169,NCT03570983,NCT00006184,NCT00574080,NCT01653418,NCT00005834,NCT00005987,NCT05294055,NCT00871013,NCT03004287,NCT01055301,NCT00002657,NCT00083538,NCT00083551,NCT00349778,NCT00003401,NCT00083681,NCT03385096,NCT00004903,NCT01548573,NCT00734877,NCT00002552,NCT00304018,NCT00005946,NCT02504359,NCT00869232
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
TOP2B,CASP3
NCT01014767 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
TOP2B
NCT03769935,NCT03100955 |
Soft tissue disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB56 |
NCT02784015,NCT01710176,NCT00876031
|
Seminoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH9FM4 |
NCT02341989,NCT01887340,NCT03937843
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2B
NCT02949258,NCT02338518 |
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT01947062,NCT00042835,NCT00020709
|
Extranodal NK/T-cell lymphoma, nasal typeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.6 |
NCT02631239,NCT04917250,NCT02825147
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
TOP2B,NCOA3
NCT00053352 |
Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associatedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.5 |
NCT01000285,NCT03007147,NCT02538926
|
Ewing sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B52 |
NCT00568464,NCT02063022,NCT01864109
|
CNS embryonal tumour, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8SH6 |
NCT00336024,NCT00006461,NCT00936156
|
GliosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9RC8 |
NCT02502708,NCT00613223,NCT00612430
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT01958372,NCT00020709,NCT00042835
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT00276809,NCT01181271,NCT00275015
|
Adrenal cortical carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KH2 |
NCT00304070,NCT03723941,NCT03583710
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
NCT00005823,NCT00006040,NCT00005863
|
Rhabdomyosarcoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0GA1 |
NCT00162695,NCT01871766,NCT00025363
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
TOP2B,CASP3,NCOA3
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
NCT00006734,NCT00014313,NCT00334867,NCT00061893,NCT00742924,NCT00470223,NCT00002516,NCT00204646,NCT00003052,NCT00002974,NCT00002936,NCT00003937,NCT00072280,NCT00077285,NCT00003141,NCT00043979,NCT00354744,NCT00379457,NCT01294670,NCT00020566
|
Kaposi sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B57 |
TOP2B
NCT00000660 |
Glioblastoma, primary, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0MB1 |
NCT02372409,NCT04765098
|
Teratoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH83G5 |
NCT00053352,NCT00104676
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT00003380,NCT00003967
|
Refractory anaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A30 |
NCT00002798,NCT00209833
|
Choroid plexus tumoursDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.22 |
NCT01014767,NCT00500890
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00003816,NCT00004904
|
GanglioneuroblastomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH77W7 |
NCT03786783,NCT02176967
|
Acute basophilic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.37 |
NCT00369317,NCT00006363
|
Other specified gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0Y |
NCT01032070,NCT02265770
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
NCOA3
NCT03017326 |
Castlemans diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B2Y |
NCT04585893,NCT02228512
|
Graft-versus-host diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B24 |
NCT00350181,NCT00004904
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
NCT00003380,NCT00003967
|
Nephroblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5QN3 |
NCT00379340,NCT05384821
|
Lymphoid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH7Q12 |
NCT03328104,NCT02523976
|
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
NCT00002926,NCT00304018,NCT02356159,NCT00005946,NCT00003816,NCT00002800,NCT00003243,NCT00774046,NCT00006363,NCT00003436,NCT01729845,NCT00005823,NCT00003602,NCT00004904,NCT00369317,NCT00005863,NCT03164057,NCT00006040,NCT00002517
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT00193596,NCT00653068,NCT00811993,NCT00003194,NCT02794571,NCT00573690,NCT04047862,NCT03617432,NCT02157792,NCT03628131,NCT00006047,NCT00027898,NCT00878449,NCT00551005,NCT00009815,NCT04469530,NCT02964013
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
TOP2B
NCT00006260,NCT00004900,NCT03923179,NCT00810017,NCT00002836,NCT01589159,NCT04452370,NCT00012311,NCT00006032,NCT00693719,NCT03535961,NCT00020722,NCT01492556,NCT00004906,NCT00002509 |
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
TOP2B
NCT00005631,NCT00003957,NCT00002488,NCT00265031,NCT00439556,NCT00920153,NCT00002941,NCT00720447,NCT00003113,NCT00002590,NCT00006455,NCT03188198,NCT00577629,NCT00002829,NCT00080886,NCT00822120,NCT00515138,NCT00242996,NCT00264953,NCT00005977,NCT00559104,NCT00002481,NCT00005090,NCT00002522,NCT01046825,NCT00641381,NCT00117598,NCT00002715,NCT00016887,NCT00933673,NCT00004086,NCT00003541,NCT00079105,NCT00025636,NCT00041210,NCT00002521,NCT00069238,NCT00002936,NCT00003575,NCT00255723,NCT00598169,NCT00002766,NCT05367856,NCT00003632,NCT00003402,NCT00003816,NCT00233987,NCT00004898,NCT00472056,NCT00002827,NCT00052923,NCT00007852,NCT00004907,NCT00003650,NCT00002987,NCT01511562,NCT00006708,NCT00695409,NCT00003578,NCT00049595,NCT00003815,NCT00058292,NCT00003243,NCT00345865,NCT00499343,NCT02436707,NCT00003423,NCT00012051,NCT00003215,NCT00002757,NCT00536978,NCT00005613,NCT00006669,NCT00002494,NCT00006373,NCT00032149,NCT00801918,NCT00006695,NCT00049439,NCT00002565,NCT00005985,NCT00003389,NCT00118209,NCT05006664,NCT00983944,NCT00039195,NCT00908180,NCT00040690,NCT00732498,NCT01329900,NCT00109928,NCT01063439,NCT00005589,NCT00416832,NCT00053768,NCT00003397,NCT00398554,NCT00002835,NCT02359162,NCT00004031,NCT00265889,NCT00003631,NCT00666484,NCT00032019,NCT00025064,NCT00569985,NCT00004010,NCT00723658,NCT00109031,NCT00005998,NCT00562978,NCT00005578,NCT00217503,NCT00003421,NCT00002905,NCT00060385,NCT00002697,NCT00577993,NCT00002461,NCT00274924,NCT00002714,NCT00003262,NCT00002982,NCT00450801,NCT00020943,NCT00039130,NCT00002471,NCT00829205,NCT00002691,NCT00521014,NCT00568607,NCT00244946,NCT00003114,NCT00005964,NCT01516567,NCT00018954,NCT00070187,NCT00028665,NCT00007865,NCT00002510,NCT00005867,NCT00002557,NCT00678327,NCT00098774,NCT00041327,NCT00004169,NCT00392834,NCT00948090,NCT01390584,NCT00003728 |
RetinoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D02.2 |
NCT00002675,NCT00554788,NCT04681417,NCT02116959,NCT00110110,NCT01899066,NCT02870907,NCT00004006,NCT00335738,NCT01906814,NCT02137928,NCT00186888,NCT01783535,NCT00072384,NCT00179920
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT00003859,NCT00003996,NCT00278278,NCT05124951,NCT00047281,NCT00278252,NCT00002876,NCT00003621,NCT00025324,NCT00004224,NCT00003309,NCT00006258,NCT00392886,NCT00084838
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT04683198,NCT00388960,NCT04624204,NCT04542369,NCT00537511,NCT04728230,NCT04063163,NCT03116971,NCT00912392,NCT04028050,NCT05142696,NCT00057837,NCT00791154,NCT02580994,NCT05245994,NCT02323737,NCT04675697,NCT05484583,NCT01237678,NCT04924101,NCT00544596,NCT04005716,NCT04422210,NCT04254471,NCT02499770,NCT05026593,NCT05116007,NCT04234607,NCT03066778,NCT00927875,NCT04774380,NCT04712903,NCT00682981,NCT04696939,NCT03699956,NCT02748889,NCT01859741,NCT03382561,NCT03850067,NCT03700359,NCT00658580,NCT00168896,NCT03059667,NCT05001412,NCT04730999,NCT04363255,NCT01555710,NCT02949895,NCT05361395,NCT04622228,NCT02738346,NCT00363415,NCT04012606,NCT04878016,NCT04346914,NCT02819999,NCT04923776,NCT02289690,NCT03389087,NCT00717938,NCT03781869,NCT02934503,NCT04490421,NCT00958022,NCT00143455,NCT04740021,NCT04543890,NCT04189094,NCT05092412,NCT01987232,NCT04660097,NCT02875457,NCT00826644,NCT05354700,NCT01563601,NCT02194049,NCT00453154,NCT05468489,NCT00017251,NCT02899728,NCT02402920,NCT04745689,NCT02722369,NCT02337712,NCT04665856,NCT05224141,NCT00043927,NCT01439568,NCT04256421,NCT03711305,NCT00401609,NCT05384015,NCT04101357,NCT05403723,NCT00526396,NCT00079040,NCT00613626,NCT05353257,NCT04472949,NCT04696575,NCT04702880,NCT01573338,NCT00916669,NCT04684017,NCT05091567,NCT03135977,NCT00977561,NCT03613597,NCT00926640,NCT00812266,NCT04560972,NCT02815592,NCT03041311,NCT00320359,NCT04699838,NCT01064466,NCT00702962,NCT01722292,NCT03043872,NCT05309629,NCT03467360,NCT00042978,NCT00887159,NCT04951115,NCT04996771,NCT02179528,NCT05161533,NCT02763579,NCT01450761,NCT00066742
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
TOP2B
NCT00003380,NCT04000295,NCT00003967,NCT02562365,NCT02867956,NCT03901118,NCT00053352,NCT00005612,NCT04520074,NCT05422183,NCT00274950,NCT03298074 |
Precursor B-lymphoblastic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A70 |
NCT00073918,NCT02845882,NCT03564704,NCT00058461,NCT00195871,NCT01451515,NCT03023046,NCT03328104,NCT03991884,NCT02881086,NCT02043587
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NCT00483561,NCT00004054,NCT02861573,NCT00176605,NCT00627354,NCT00028769,NCT00151060,NCT00973882,NCT00003084,NCT00514540
|
Medulloblastoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8P29 |
NCT01857453,NCT04501718,NCT02502708,NCT00749723,NCT01356290,NCT00031590,NCT00336024,NCT02025881,NCT00180791,NCT00006461
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
NCT00002596,NCT00231582,NCT00002566,NCT00936936,NCT00053352,NCT00324298,NCT00104676,NCT03937843,NCT02341989,NCT00003941
|
Mantle cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85.5 |
NCT03019640,NCT00571493,NCT02896582,NCT00073918,NCT00086944,NCT00114738,NCT00878254,NCT00209222,NCT01181271,NCT00005780
|
Anogenital wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A95 |
TOP2B
|
SyphilisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A61-1A6Z |
TOP2B
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
TOP2B
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
TOP2B
|
Urinary tract infectionDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC08 |
TOP2B
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
TOP2B
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
TOP2B
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
TOP2B
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
TOP2B
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
TOP2B
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
TOP2B
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
TOP2B
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
TOP2B
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
TOP2B
|
Common wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E80 |
TOP2B
|
ChemoprotectionDisease Category: NADisease ICD-11 Code: N.A. |
TOP2B
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
TOP2B
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
TOP2B
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
TOP2B
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
TOP2B
|
Gonococcal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A70-1A7Z |
TOP2B
|
Waldenstrom macroglobulinemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH8GW4 |
NCT00073918
|
Relapsing-remitting multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40.0 |
NCT00288626
|
Tumours of neuroepithelial tissue of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.2 |
NCT02653196
|
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT03669783
|
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85.1 |
NCT00073918
|
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
NCT02504359
|
Oligodendroglioma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH8844 |
NCT00303849
|
Chronic myeloid leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4XG8 |
NCT00780104
|
ThymomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NCT00387868
|
Refractory anaemia with excess of blastsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A35 |
NCT00002798
|
OligoastrocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH6F49 |
NCT02372409
|
Adult T-cell leukaemia/lymphoma (HTLV-1 positive)Disease Category: X.Extension CodesDisease ICD-11 Code: XH6TE2 |
NCT00145002
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT00351195
|
Myasthenia gravisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C6Y |
NCT00716066
|
Inappropriate saccadesDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C85.02 |
NCT00716066
|
Diseases of the blood or blood-forming organs, unspecifiedDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
NCT01220297
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
NCT02633514
|
Ependymoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1511 |
NCT02502708
|
Embryonal rhabdomyosarcoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH83G1 |
NCT01055314
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT00202800
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
NCT00002798
|
Malignant trophoblastic neoplasms of placentaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C75.0 |
NCT02639650
|
Ependymoma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH6922 |
NCT01096368
|
Other specified malignant neoplasms of the ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.Y |
NCT02429700
|
Small cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH0YB0 |
NCT05058651
|
Human immunodeficiency virus type 1Disease Category: X.Extension CodesDisease ICD-11 Code: XN8LD |
NCT01435018
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04356690
|
Oligodendroglioma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH7W59 |
NCT02372409
|
Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cordDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E4A.0 |
NCT00716066
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
NCT04322318
|
Congenital human immunodeficiency virus infectionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA62.6 |
NCT02199184
|
Malignant neoplasm metastasis in mediastinumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D71 |
NCT00003941
|
Chronic inflammatory demyelinating polyneuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C01.3 |
NCT00716066
|
Alveolar rhabdomyosarcomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7099 |
NCT01055314
|
Mature B-cell neoplasms, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A8Z |
NCT02911142
|
Malignant neoplasms of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A |
NCT01525927
|
Skin cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30-2C37 |
NCT01013779
|
Astrocytoma, anaplasticDisease Category: X.Extension CodesDisease ICD-11 Code: XH96C7 |
NCT02372409
|
Myeloid sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.39 |
NCT01371981
|
Neuromyelitis opticaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A43 |
NCT00716066
|
Neuroendocrine neoplasms of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.1 |
NCT02595424
|
Myeloproliferative and myelodysplastic disease, unclassifiableDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A44 |
NCT00003243
|
Pilocytic astrocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH12D2 |
NCT02372409
|
Glioma, malignantDisease Category: X.Extension CodesDisease ICD-11 Code: XH4RQ3 |
NCT01756989
|
NeutropeniaDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4B00 |
NCT00002800
|
Embryonal carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8MB9 |
NCT00053352
|
T lymphoblastic leukaemia/lymphomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH50W7 |
NCT02538926
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
NCT03980925
|
Optic nerve disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C40 |
NCT02372409
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
CASP3
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
CASP3
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CASP3
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CASP3
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
CASP3
|